Bone Biopsy (BB) with histomorphometric analysis still represents the gold standard for the diagnosis and classification of different forms of renal osteodystrophy. Bone biopsy is the only technique able to provide comprehensive information on all bone parameters, measuring static and dynamic parameters of turnover, cortical and trabecular microarchitecture, and mineralization defects. In nephrological practice, bone biopsy yields relevant indications to support therapeutic choices in CKD, heavily impacting the management and prognosis of uremic patients. Unfortunately, the use of bone biopsy has decreased; a lack of expertise in performing and interpreting, perceived procedure invasiveness and pain, and reimbursement issues have all contributed to this decline. Nevertheless, both bone biomarkers and instrumental images cannot be considered reliable surrogates for histological findings, being insufficiently accurate to properly evaluate underlying mineral and bone disorders. This is a multidisciplinary position paper from the Nephrology and Osteoporosis Italian Scientific Societies with the purpose of restating the role of bone biopsy in CKD patient management and of providing strong solutions to allow diffusion of this technique in Italy, but potentially also in other countries. The Italian approach through the optimization and standardization of bone biopsy procedure, the construction of the Italian Hub and Spoke network, and a request for adjustment and national homogenization of reimbursement to the Italian Health Ministry has led the way to implement bone biopsy and to improve CKD patient management and prognosis.

Time for revival of bone biopsy with histomorphometric analysis in Chronic Kidney Disease (CKD) : moving from skepticism to pragmatism / M. Fusaro, G.V. Re Sarto', M. Gallieni, L. Cosmai, P.G. Messa, M. Rossini, I. Chiodini, M. Plebani, P. Evenepoel, N. Harvey, S. Ferrari, J. Cannata-Andia, A. Trombetti, M.L. Brandi, M. Ketteler, T.L. Nickolas, J. Cunningham, S. Salam, C. Della Rocca, A. Scarpa, S. Minisola, F. Malberti, F. Cetani, M. Cozzolino, S. Mazzaferro, L. Morrone, G. Tripepi, M. Zaninotto, M.C. Mereu, M. Ravera, G. Cianciolo, G. La Manna, A. Aghi, S. Giannini, L. Dalle Carbonare. - In: NUTRIENTS. - ISSN 2072-6643. - 14:9(2022 Apr 22), pp. 1742.1-1742.15. [10.3390/nu14091742]

Time for revival of bone biopsy with histomorphometric analysis in Chronic Kidney Disease (CKD) : moving from skepticism to pragmatism

G.V. Re Sarto';M. Gallieni;I. Chiodini;M. Cozzolino;
2022-04-22

Abstract

Bone Biopsy (BB) with histomorphometric analysis still represents the gold standard for the diagnosis and classification of different forms of renal osteodystrophy. Bone biopsy is the only technique able to provide comprehensive information on all bone parameters, measuring static and dynamic parameters of turnover, cortical and trabecular microarchitecture, and mineralization defects. In nephrological practice, bone biopsy yields relevant indications to support therapeutic choices in CKD, heavily impacting the management and prognosis of uremic patients. Unfortunately, the use of bone biopsy has decreased; a lack of expertise in performing and interpreting, perceived procedure invasiveness and pain, and reimbursement issues have all contributed to this decline. Nevertheless, both bone biomarkers and instrumental images cannot be considered reliable surrogates for histological findings, being insufficiently accurate to properly evaluate underlying mineral and bone disorders. This is a multidisciplinary position paper from the Nephrology and Osteoporosis Italian Scientific Societies with the purpose of restating the role of bone biopsy in CKD patient management and of providing strong solutions to allow diffusion of this technique in Italy, but potentially also in other countries. The Italian approach through the optimization and standardization of bone biopsy procedure, the construction of the Italian Hub and Spoke network, and a request for adjustment and national homogenization of reimbursement to the Italian Health Ministry has led the way to implement bone biopsy and to improve CKD patient management and prognosis.
bone biopsy; chronic kidney disease; CKD-MBD; fractures; osteoporosis; renal osteodystrophy; biopsy; bone and bones; female; humans; male; chronic kidney disease-mineral and bone disorder; osteoporosis; renal insufficiency, chronic
Settore MED/13 - Endocrinologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
167 - Bone Biopsy Position Paper - Nutrients 2022.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.63 MB
Formato Adobe PDF
1.63 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/932731
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact